Vivos Therapeutics, Inc. VVOS Q2 2025 earnings
Reported August 19, 2025 · Before market open
Revenue$3.8MBeat by $166.6K
EPS-$0.55Miss by $0.28
Revenue estimate$3.7M
EPS estimate-$0.27
Next report
Aug 18, 2026 (In 2 weeks)Revenue estimate$5.6M
EPS estimate-$0.42
Versus estimates
Revenue
Diluted EPS
Ask the moment Vivos Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Vivos Therapeutics, Inc. report Q2 2025 earnings?
- Vivos Therapeutics, Inc. (VVOS) reported Q2 2025 earnings on August 19, 2025 before market open.
- What were Vivos Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Vivos Therapeutics, Inc. reported revenue of $3.8M and eps of $-0.55 for Q2 2025.
- Did Vivos Therapeutics, Inc. beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $3.7M by $166.6K. EPS missed the consensus estimate of $-0.27 by $0.28.
- How did Vivos Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 5.8% from $4.1M a year earlier and eps grew 8.3% from $-0.60.
- Where can I find Vivos Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001641172-25-024832) directly on SEC EDGAR. The filing index links above go to sec.gov.